Emavusertib
- Generic Name
- Emavusertib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H25N7O5
- CAS Number
- 1801344-14-8
- Unique Ingredient Identifier
- MH5DMF9JKY
- Associated Conditions
- -
- Associated Therapies
- -
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Phase 1
Not yet recruiting
- Conditions
- Unresectable Urothelial CarcinomaMetastatic Urothelial Carcinoma
- Interventions
- Procedure: BiopsyProcedure: Biospecimen CollectionProcedure: Computed TomographyBiological: EmavusertibProcedure: Magnetic Resonance ImagingBiological: PembrolizumabProcedure: Positron Emission Tomography
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 25
- Registration Number
- NCT06439836
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Metastatic Pancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Unresectable Pancreatic Ductal Adenocarcinoma
- Interventions
- Procedure: BiopsyProcedure: Biospecimen CollectionProcedure: Computed TomographyBiological: EmavusertibDrug: Gemcitabine HydrochlorideProcedure: Magnetic Resonance ImagingDrug: Nab-paclitaxelProcedure: Positron Emission TomographyProcedure: X-Ray Imaging
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 36
- Registration Number
- NCT05685602
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
🇺🇸UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath